Introduction: What they say:
A recent study from the Institute of Biophysics, Chinese Academy of Sciences, Beijing, China shows that “Sox2 functions as a sequence-specific DNA sensor in neutrophils to initiate innate immunity against microbial infection.” This study was published, in the 2 March 2015 issue of the Journal “Nature Immunology” [the number one journal in immunological research with an impact factor of 24.973], by Drs. Zusen Fan, Xia and others.
What we say:
On the foundation of this interesting finding, Dr L Boominathan PhD, the Director-cum-chief Scientist of GBMD, reports that: Oats as an Immune booster: Oats-based immune enhancement therapy: Avenanthramide C, found in Oats, increases SOX2 expression, and promotes innate immunity against bacterial infection, via down-regulation of its target gene
From Research Findings to Therapeutic Opportunity:
This study suggests, for the first time, Avenanthramide C, by decreasing the expression of its target gene, it may : (1) increase the expression of Sox2; (2) increase the ability of Sox2 to recognize bacterial DNA in the cytoplasm; and (3) promote innate immunity against bacterial infection.
Together,pharmacological formulations encompassing “Avenanthramide C or its analogs, either alone or in combination with other drugs,” may be used to (1) enhance innate immunity against bacterial infection; and (2) promote bacterial resistance (figs. 1-2).
Details of the research findings:
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Undisclosed mechanistic information: How does Avenanthramide C enhance innate immunity against bacterial infections?
# Research cooperation
For purchase and payment details, you may reach us at firstname.lastname@example.org
Citation: Boominathan, L., Oats as an Immune booster: Oats-based immune enhancement therapy: Avenanthramide C, found in Oats, increases SOX2 expression, and promotes innate immunity against bacterial infection, via down-regulation of its target gene, 15/April/2019, 8.01 pm, Genome-2-BioMedicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at email@example.com